首页 › 基金 › Octagon Capital Advisors LP › PHVS

Octagon Capital Advisors LP 对 PHVS 的持仓历史

PHARVARIS N V · 医疗保健

Octagon Capital Advisors LP 在 Q3 2026 的 13F 申报中披露持有 PHVS(PHARVARIS N V)249,000 股,市值约 US$7.9M,约占其申报组合的 1.05%,在其申报持仓中市值排名第 18 位。 Octagon Capital Advisors LP 最近 9 个申报季度中有 9 个季度披露了 PHVS 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q3 2026)249.00K 股
申报持仓市值$7.90M
组合权重1.05%
首次申报Q3 2024
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Octagon Capital Advisors LP 对 PHVS 的持仓演变

Octagon Capital Advisors LP 于 Q3 2024 首次披露 PHVS 持仓:620,470 股(约 US$11.5M)。 该持仓在 Q4 2025 达到峰值 671,465 股,市值约 US$18.6M。 在 9 次申报中,Octagon Capital Advisors LP 3 次增持、5 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 249,000 股、市值约 US$7.9M,环比减持 -207,721 股。。 持仓曾出现大幅变动:Q1 2026 减持约 75% (随后一个季度股价上涨 22%)、Q2 2026 增持约 177% (随后一个季度股价下跌 8%)、Q3 2026 减持约 45% (随后一个季度股价上涨 2%)。

逐季持仓明细

季度股数金额变化
Q3 2024 620.47K $11.49M 新进
Q4 2024 778.00K $14.91M 增持
Q1 2025 769.82K $12.09M 减持
Q2 2025 672.60K $11.84M 减持
Q3 2025 722.60K $18.03M 增持
Q4 2025 671.47K $18.63M 减持
Q1 2026 165.00K $4.66M 减持
Q2 2026 456.72K $15.79M 增持
Q3 2026 249.00K $7.90M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PHVS 与 13F 数据

PHVS(PHARVARIS N V)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 PHVS,申报仓位最大的包括:Foresite Capital Management IV, LLC (US$151.6M), venBio Partners LLC (US$141.4M), EQT Fund Management S.a r.l. (US$108.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PHVS 的基金

查看 PHVS 的全部基金持有人 →

常见问题

How long has Octagon Capital Advisors LP held PHVS?

Octagon Capital Advisors LP has disclosed PHVS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Octagon Capital Advisors LP's current position in PHVS?

As of Q3 2026, Octagon Capital Advisors LP holds 249.00K shares of PHVS (PHARVARIS N V), valued at $7.90M, representing 1.05% of its reported portfolio and ranking #18.

Has Octagon Capital Advisors LP been buying or selling PHVS?

In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP reduced its position in PHVS. The position peaked in Q4 2025 at 671.47K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include Foresite Capital Management IV, LLC, venBio Partners LLC, EQT Fund Management S.a r.l., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.